ArticleLeukemia2019

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1.

H Pfeifer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.